A--Whole-person Assessment of Response and Risk after transformative therapies: In
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD) is a sources-sought opportunity issued by the National Institutes of Health under the Department of Health and Human Services. This initiative focuses on evaluating the outcomes and resilience of patients undergoing transformative therapies for Sickle Cell Disease. The project is categorized under NAICS code 541715, indicating a focus on research and development in the physical, engineering, and life sciences. The solicitation, numbered 75N98026R00146, was posted on September 2, 2026, with a response deadline of October 2, 2026. Managed by the NIH office in Bethesda, Maryland, the primary point of contact for this effort is Elizabeth R. Bulger. This procurement process is designed to identify capable sources for the comprehensive assessment of patient responses to these medical interventions.
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
